<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Urinary Incontinence in Women - Clinical Guide</title>
    <link href="https://fonts.googleapis.com/css2?family=Inter:wght@300;400;500;600;700&display=swap" rel="stylesheet">
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.4.0/css/all.min.css">
    <style>
        :root {
            --primary: #4a90e2;
            --primary-dark: #3a7bc8;
            --secondary: #7b68ee;
            --success: #52c41a;
            --warning: #faad14;
            --danger: #f5222d;
            --light: #f0f7ff;
            --white: #ffffff;
            --gray-light: #f5f7fa;
            --gray: #e1e4e8;
            --gray-dark: #6c757d;
            --text: #333333;
            --shadow: 0 2px 8px rgba(0,0,0,0.1);
            --shadow-hover: 0 4px 12px rgba(0,0,0,0.15);
        }

        * {
            margin: 0;
            padding: 0;
            box-sizing: border-box;
        }

        body {
            font-family: 'Inter', sans-serif;
            line-height: 1.6;
            color: var(--text);
            background-color: #f8fafc;
            padding: 0;
            margin: 0;
        }

        .container {
            max-width: 1200px;
            margin: 0 auto;
            padding: 0 20px;
        }

        header {
            background: linear-gradient(135deg, var(--primary) 0%, var(--secondary) 100%);
            color: var(--white);
            padding: 2rem 0;
            box-shadow: var(--shadow);
        }

        .header-content {
            display: flex;
            justify-content: space-between;
            align-items: center;
        }

        .header-content h1 {
            font-size: 2rem;
            font-weight: 700;
        }

        .header-content .subtitle {
            font-size: 1.1rem;
            opacity: 0.9;
            margin-top: 0.5rem;
        }

        .last-revised {
            background-color: rgba(255,255,255,0.2);
            padding: 0.5rem 1rem;
            border-radius: 20px;
            font-size: 0.9rem;
        }

        nav {
            background-color: var(--white);
            padding: 1rem 0;
            box-shadow: var(--shadow);
            position: sticky;
            top: 0;
            z-index: 100;
        }

        .nav-tabs {
            display: flex;
            overflow-x: auto;
            gap: 0.5rem;
        }

        .nav-tab {
            padding: 0.75rem 1.5rem;
            border-radius: 8px;
            background-color: var(--gray-light);
            color: var(--text);
            text-decoration: none;
            font-weight: 500;
            white-space: nowrap;
            transition: all 0.3s ease;
        }

        .nav-tab:hover {
            background-color: var(--light);
            transform: translateY(-2px);
        }

        .nav-tab.active {
            background-color: var(--primary);
            color: var(--white);
        }

        main {
            padding: 2rem 0;
        }

        .section {
            background-color: var(--white);
            border-radius: 12px;
            padding: 2rem;
            margin-bottom: 2rem;
            box-shadow: var(--shadow);
            transition: transform 0.3s ease, box-shadow 0.3s ease;
        }

        .section:hover {
            transform: translateY(-3px);
            box-shadow: var(--shadow-hover);
        }

        .section-header {
            display: flex;
            align-items: center;
            margin-bottom: 1.5rem;
            padding-bottom: 1rem;
            border-bottom: 2px solid var(--gray-light);
        }

        .section-icon {
            width: 40px;
            height: 40px;
            border-radius: 8px;
            display: flex;
            align-items: center;
            justify-content: center;
            margin-right: 1rem;
            color: var(--white);
            font-size: 1.2rem;
        }

        .definition .section-icon { background-color: var(--primary); }
        .causes .section-icon { background-color: var(--secondary); }
        .prevalence .section-icon { background-color: var(--success); }
        .complications .section-icon { background-color: var(--warning); }
        .assessment .section-icon { background-color: var(--primary); }
        .management .section-icon { background-color: var(--success); }
        .referral .section-icon { background-color: var(--danger); }

        .section-title {
            font-size: 1.5rem;
            font-weight: 600;
            color: var(--text);
        }

        .content-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(300px, 1fr));
            gap: 1.5rem;
        }

        .card {
            background-color: var(--gray-light);
            border-radius: 8px;
            padding: 1.5rem;
            transition: all 0.3s ease;
        }

        .card:hover {
            transform: translateY(-3px);
            box-shadow: var(--shadow);
        }

        .card-title {
            font-weight: 600;
            margin-bottom: 0.75rem;
            color: var(--primary-dark);
            display: flex;
            align-items: center;
        }

        .card-title i {
            margin-right: 0.5rem;
        }

        .card-content {
            font-size: 0.95rem;
        }

        ul, ol {
            padding-left: 1.5rem;
            margin-bottom: 1rem;
        }

        li {
            margin-bottom: 0.5rem;
        }

        .highlight {
            background-color: var(--light);
            padding: 0.2rem 0.4rem;
            border-radius: 4px;
            font-weight: 500;
        }

        .red-flag {
            background-color: rgba(245, 34, 45, 0.1);
            border-left: 4px solid var(--danger);
            padding: 1rem;
            margin: 1rem 0;
            border-radius: 0 8px 8px 0;
        }

        .red-flag-title {
            color: var(--danger);
            font-weight: 600;
            margin-bottom: 0.5rem;
            display: flex;
            align-items: center;
        }

        .red-flag-title i {
            margin-right: 0.5rem;
        }

        .timeline {
            position: relative;
            padding-left: 2rem;
        }

        .timeline::before {
            content: '';
            position: absolute;
            left: 0.5rem;
            top: 0;
            height: 100%;
            width: 2px;
            background-color: var(--gray);
        }

        .timeline-item {
            position: relative;
            margin-bottom: 1.5rem;
        }

        .timeline-item::before {
            content: '';
            position: absolute;
            left: -1.5rem;
            top: 0.5rem;
            width: 12px;
            height: 12px;
            border-radius: 50%;
            background-color: var(--primary);
        }

        .timeline-date {
            font-weight: 600;
            color: var(--primary);
            margin-bottom: 0.25rem;
        }

        .timeline-content {
            background-color: var(--gray-light);
            padding: 0.75rem;
            border-radius: 8px;
        }

        .tag {
            display: inline-block;
            padding: 0.25rem 0.75rem;
            border-radius: 20px;
            font-size: 0.85rem;
            font-weight: 500;
            margin-right: 0.5rem;
            margin-bottom: 0.5rem;
        }

        .tag-primary { background-color: var(--light); color: var(--primary); }
        .tag-success { background-color: rgba(82, 196, 26, 0.1); color: var(--success); }
        .tag-warning { background-color: rgba(250, 173, 20, 0.1); color: var(--warning); }
        .tag-danger { background-color: rgba(245, 34, 45, 0.1); color: var(--danger); }

        .info-box {
            background-color: var(--light);
            border-radius: 8px;
            padding: 1.5rem;
            margin: 1.5rem 0;
        }

        .info-box-title {
            font-weight: 600;
            margin-bottom: 0.75rem;
            color: var(--primary-dark);
        }

        footer {
            background-color: var(--gray-dark);
            color: var(--white);
            padding: 1.5rem 0;
            text-align: center;
            font-size: 0.9rem;
        }

        .copyright {
            margin-bottom: 0.5rem;
        }

        .disclaimer {
            opacity: 0.8;
            font-size: 0.85rem;
        }

        @media (max-width: 768px) {
            .header-content {
                flex-direction: column;
                text-align: center;
            }

            .header-content h1 {
                font-size: 1.5rem;
            }

            .last-revised {
                margin-top: 1rem;
            }

            .nav-tabs {
                justify-content: flex-start;
            }

            .content-grid {
                grid-template-columns: 1fr;
            }
        }
    </style>
</head>
<body>
    <header>
        <div class="container">
            <div class="header-content">
                <div>
                    <h1>Urinary Incontinence in Women</h1>
                    <div class="subtitle">Clinical Knowledge Summary</div>
                </div>
                <div class="last-revised">
                    <i class="far fa-calendar-alt"></i> Last revised: January 2025
                </div>
            </div>
        </div>
    </header>

    <nav>
        <div class="container">
            <div class="nav-tabs">
                <a href="#overview" class="nav-tab active">Overview</a>
                <a href="#definition" class="nav-tab">Definition</a>
                <a href="#causes" class="nav-tab">Causes</a>
                <a href="#prevalence" class="nav-tab">Prevalence</a>
                <a href="#complications" class="nav-tab">Complications</a>
                <a href="#assessment" class="nav-tab">Assessment</a>
                <a href="#management" class="nav-tab">Management</a>
                <a href="#referral" class="nav-tab">Referral</a>
                <a href="#updates" class="nav-tab">Updates</a>
            </div>
        </div>
    </nav>

    <main>
        <div class="container">
            <section id="overview" class="section">
                <div class="section-header">
                    <div class="section-icon"><i class="fas fa-info-circle"></i></div>
                    <h2 class="section-title">Overview</h2>
                </div>
                <div class="info-box">
                    <div class="info-box-title">Topic Coverage</div>
                    <p>This CKS topic covers the primary care management of urinary incontinence (UI) in women from age 18 years onwards.</p>
                    <p class="mt-2">It does not cover specialist management of UI in women or management of UI in men or children.</p>
                </div>
                <div class="info-box">
                    <div class="info-box-title">Target Audience</div>
                    <p>Healthcare professionals working within the NHS in the UK, providing first contact or primary healthcare.</p>
                </div>
            </section>

            <section id="definition" class="section definition">
                <div class="section-header">
                    <div class="section-icon"><i class="fas fa-book-medical"></i></div>
                    <h2 class="section-title">Definition</h2>
                </div>
                <p>Urinary incontinence is defined as any involuntary leakage of urine.</p>
                <div class="content-grid mt-3">
                    <div class="card">
                        <div class="card-title"><i class="fas fa-running"></i> Stress Urinary Incontinence</div>
                        <div class="card-content">
                            Involuntary leakage on effort, exertion, sneezing, or coughing.
                        </div>
                    </div>
                    <div class="card">
                        <div class="card-title"><i class="fas fa-clock"></i> Urgency Urinary Incontinence</div>
                        <div class="card-content">
                            Involuntary leakage accompanied or immediately preceded by urgency.
                        </div>
                    </div>
                    <div class="card">
                        <div class="card-title"><i class="fas fa-random"></i> Mixed Urinary Incontinence</div>
                        <div class="card-content">
                            Involuntary leakage associated with both urgency and physical stress.
                        </div>
                    </div>
                    <div class="card">
                        <div class="card-title"><i class="fas fa-tint"></i> Other Types</div>
                        <div class="card-content">
                            <ul>
                                <li>Overflow incontinence (chronic urinary retention)</li>
                                <li>Continuous urinary incontinence</li>
                                <li>Situational incontinence</li>
                            </ul>
                        </div>
                    </div>
                </div>
            </section>

            <section id="causes" class="section causes">
                <div class="section-header">
                    <div class="section-icon"><i class="fas fa-search"></i></div>
                    <h2 class="section-title">Causes and Contributing Factors</h2>
                </div>
                <div class="content-grid">
                    <div class="card">
                        <div class="card-title"><i class="fas fa-female"></i> Stress UI Risk Factors</div>
                        <div class="card-content">
                            <ul>
                                <li>Pregnancy, parity, and vaginal delivery</li>
                                <li>Obesity</li>
                                <li>High-impact activities</li>
                                <li>Pelvic and vaginal surgeries</li>
                                <li>Genetic and family history</li>
                                <li>Constipation</li>
                                <li>Smoking</li>
                                <li>Menopause</li>
                                <li>Certain medications (ACE inhibitors, alpha-blockers)</li>
                            </ul>
                        </div>
                    </div>
                    <div class="card">
                        <div class="card-title"><i class="fas fa-brain"></i> Urgency UI Risk Factors</div>
                        <div class="card-content">
                            <ul>
                                <li>Neurological conditions (Parkinson's, MS, stroke)</li>
                                <li>Recurrent UTIs</li>
                                <li>Urinary tract obstruction</li>
                                <li>Diabetes</li>
                                <li>Menopause</li>
                                <li>Caffeinated or alcoholic drinks</li>
                                <li>High or low fluid intake</li>
                                <li>Smoking</li>
                                <li>Certain medications (sympathomimetics, antidepressants, diuretics)</li>
                            </ul>
                        </div>
                    </div>
                </div>
            </section>

            <section id="prevalence" class="section prevalence">
                <div class="section-header">
                    <div class="section-icon"><i class="fas fa-chart-bar"></i></div>
                    <h2 class="section-title">Prevalence</h2>
                </div>
                <div class="info-box">
                    <div class="info-box-title">Key Statistics</div>
                    <ul>
                        <li>Estimated <span class="highlight">34% of UK women</span> are living with UI</li>
                        <li>Prevalence increases with age, particularly in postmenopausal period</li>
                        <li>Only <span class="highlight">17% of women with UI</span> seek professional help</li>
                        <li>Stress UI is most common (24%), followed by mixed UI (20%) and OAB/UUI (7%)</li>
                    </ul>
                </div>
                <div class="content-grid">
                    <div class="card">
                        <div class="card-title"><i class="fas fa-globe"></i> Global Variation</div>
                        <div class="card-content">
                            In women aged 55-106 years, prevalence varies by region:
                            <ul>
                                <li>Highest in Asia (45.1%)</li>
                                <li>Lowest in America (25.8%)</li>
                            </ul>
                        </div>
                    </div>
                    <div class="card">
                        <div class="card-title"><i class="fas fa-birthday-cake"></i> Age Patterns</div>
                        <div class="card-content">
                            <ul>
                                <li>SUI peak age: 35-44 years</li>
                                <li>MUI peak age: 55-64 years</li>
                                <li>OAB peak age: 65-74 years</li>
                                <li>UUI has two peaks: ≤24 years and >75 years</li>
                            </ul>
                        </div>
                    </div>
                </div>
            </section>

            <section id="complications" class="section complications">
                <div class="section-header">
                    <div class="section-icon"><i class="fas fa-exclamation-triangle"></i></div>
                    <h2 class="section-title">Complications</h2>
                </div>
                <div class="content-grid">
                    <div class="card">
                        <div class="card-title"><i class="fas fa-heart"></i> Emotional & Psychological</div>
                        <div class="card-content">
                            <ul>
                                <li>Low self-esteem and self-confidence</li>
                                <li>Anxiety and depression</li>
                                <li>Embarrassment or feelings of shame</li>
                            </ul>
                        </div>
                    </div>
                    <div class="card">
                        <div class="card-title"><i class="fas fa-user-injured"></i> Physical</div>
                        <div class="card-content">
                            <ul>
                                <li>Skin breakdown and infections</li>
                                <li>Urinary tract infections</li>
                                <li>Falls (from slipping on urine)</li>
                            </ul>
                        </div>
                    </div>
                    <div class="card">
                        <div class="card-title"><i class="fas fa-heart-broken"></i> Sexual & Social</div>
                        <div class="card-content">
                            <ul>
                                <li>Reduced intimacy and affection</li>
                                <li>Avoidance of sexual activity</li>
                                <li>Social isolation</li>
                                <li>Sleep disturbance</li>
                            </ul>
                        </div>
                    </div>
                    <div class="card">
                        <div class="card-title"><i class="fas fa-pound-sign"></i> Economic</div>
                        <div class="card-content">
                            <ul>
                                <li>Cost of absorbent products and laundry</li>
                                <li>Reduced employment and productivity</li>
                                <li>Annual NHS cost: £536 million</li>
                                <li>Total yearly service costs: £743 million</li>
                            </ul>
                        </div>
                    </div>
                </div>
            </section>

            <section id="assessment" class="section assessment">
                <div class="section-header">
                    <div class="section-icon"><i class="fas fa-stethoscope"></i></div>
                    <h2 class="section-title">Assessment</h2>
                </div>
                <div class="content-grid">
                    <div class="card">
                        <div class="card-title"><i class="fas fa-notes-medical"></i> History</div>
                        <div class="card-content">
                            <ul>
                                <li>Categorize UI type (SUI, UUI/OAB, MUI)</li>
                                <li>Ask about associated voiding and urinary symptoms</li>
                                <li>Identify underlying causes and contributing factors</li>
                                <li>Ask about medications that may cause or exacerbate UI</li>
                                <li>Inquire about possible complications</li>
                            </ul>
                        </div>
                    </div>
                    <div class="card">
                        <div class="card-title"><i class="fas fa-search-plus"></i> Examination</div>
                        <div class="card-content">
                            <ul>
                                <li>General examination (weight, gait, neurological signs)</li>
                                <li>Abdominal examination for palpable bladder</li>
                                <li>Pelvic examination:
                                    <ul>
                                        <li>Observe leakage with cough</li>
                                        <li>Check for prolapse, atrophic vaginitis, urethral diverticulum</li>
                                        <li>Assess pelvic floor muscle tone and contraction</li>
                                    </ul>
                                </li>
                            </ul>
                        </div>
                    </div>
                    <div class="card">
                        <div class="card-title"><i class="fas fa-flask"></i> Investigations</div>
                        <div class="card-content">
                            <ul>
                                <li>Urine dipstick analysis (all women)</li>
                                <li>MSU culture if UTI suspected</li>
                                <li>Renal function assessment if obstruction suspected</li>
                                <li>Bladder diary (minimum 3 days)</li>
                            </ul>
                        </div>
                    </div>
                </div>
                <div class="info-box mt-3">
                    <div class="info-box-title">Pelvic Floor Muscle Assessment (Oxford Grading)</div>
                    <div class="content-grid">
                        <div class="card">
                            <div class="card-title">0-2 (Weak)</div>
                            <div class="card-content">
                                <ul>
                                    <li>0 = No contraction</li>
                                    <li>1 = Flicker or pulsation</li>
                                    <li>2 = Weak contraction without lift</li>
                                </ul>
                            </div>
                        </div>
                        <div class="card">
                            <div class="card-title">3-5 (Strong)</div>
                            <div class="card-content">
                                <ul>
                                    <li>3 = Moderate contraction with lift</li>
                                    <li>4 = Good contraction against resistance</li>
                                    <li>5 = Strong contraction with squeeze</li>
                                </ul>
                            </div>
                        </div>
                    </div>
                </div>
            </section>

            <section id="management" class="section management">
                <div class="section-header">
                    <div class="section-icon"><i class="fas fa-user-md"></i></div>
                    <h2 class="section-title">Management</h2>
                </div>
                <div class="content-grid">
                    <div class="card">
                        <div class="card-title"><i class="fas fa-heartbeat"></i> First-line Treatments</div>
                        <div class="card-content">
                            <ul>
                                <li><span class="tag tag-success">SUI</span> Supervised pelvic floor muscle training (≥3 months)</li>
                                <li><span class="tag tag-success">UUI/OAB</span> Bladder training (≥6 weeks)</li>
                                <li><span class="tag tag-success">MUI</span> Combination of approaches above</li>
                            </ul>
                        </div>
                    </div>
                    <div class="card">
                        <div class="card-title"><i class="fas fa-pills"></i> Pharmacotherapy for OAB</div>
                        <div class="card-content">
                            <ul>
                                <li>Antimuscarinic medications</li>
                                <li>Mirabegron (β3-adrenoceptor agonist)</li>
                                <li><span class="tag tag-primary">New (2024)</span> Vibegron (if antimuscarinics unsuitable/ineffective)</li>
                                <li>Desmopressin for troublesome nocturia and urgency incontinence</li>
                            </ul>
                        </div>
                    </div>
                    <div class="card">
                        <div class="card-title"><i class="fas fa-leaf"></i> Lifestyle Modifications</div>
                        <div class="card-content">
                            <ul>
                                <li>Weight loss if BMI >30 kg/m²</li>
                                <li>Fluid intake adjustment</li>
                                <li>Caffeine reduction (especially for OAB)</li>
                                <li>Smoking cessation</li>
                                <li>Management of constipation</li>
                            </ul>
                        </div>
                    </div>
                    <div class="card">
                        <div class="card-title"><i class="fas fa-shield-alt"></i> Containment Products</div>
                        <div class="card-content">
                            <p>Should be offered only as:</p>
                            <ul>
                                <li>A temporary coping strategy, or</li>
                                <li>Long-term management if treatment is unsuccessful</li>
                            </ul>
                        </div>
                    </div>
                </div>
            </section>

            <section id="referral" class="section referral">
                <div class="section-header">
                    <div class="section-icon"><i class="fas fa-ambulance"></i></div>
                    <h2 class="section-title">Referral Guidelines</h2>
                </div>
                <div class="red-flag">
                    <div class="red-flag-title"><i class="fas fa-exclamation-circle"></i> Urgent Referral (2-week cancer pathway)</div>
                    <ul>
                        <li>Age ≥45 with unexplained visible haematuria without UTI</li>
                        <li>Age ≥45 with visible haematuria persistent/recurrent after UTI treatment</li>
                        <li>Age ≥60 with unexplained non-visible haematuria AND dysuria or raised WBC</li>
                    </ul>
                </div>
                <div class="red-flag">
                    <div class="red-flag-title"><i class="fas fa-exclamation-circle"></i> Specialist Referral</div>
                    <ul>
                        <li>Persistent bladder or urethral pain (urgent if cancer suspected)</li>
                        <li>Voiding difficulty or history of chronic urinary retention</li>
                        <li>Palpable bladder after voiding</li>
                        <li>Clinically benign pelvic mass</li>
                        <li>Associated faecal incontinence</li>
                        <li>Suspected neurological disease</li>
                        <li>Suspected urogenital fistulae</li>
                        <li>History of previous incontinence surgery, pelvic cancer surgery, or radiation therapy</li>
                        <li>Recurrent UTI (consider non-urgent referral for bladder cancer in women ≥60)</li>
                    </ul>
                </div>
            </section>

            <section id="updates" class="section">
                <div class="section-header">
                    <div class="section-icon"><i class="fas fa-sync-alt"></i></div>
                    <h2 class="section-title">Recent Updates</h2>
                </div>
                <div class="timeline">
                    <div class="timeline-item">
                        <div class="timeline-date">December 2024</div>
                        <div class="timeline-content">
                            <strong>Major Review:</strong> Vibegron added as treatment option for overactive bladder symptoms if antimuscarinic medicines are unsuitable, ineffective, or not tolerated. Topic restructured for improved navigation.
                        </div>
                    </div>
                    <div class="timeline-item">
                        <div class="timeline-date">July 2024</div>
                        <div class="timeline-content">
                            <strong>Minor Update:</strong> Neuroleptic malignant syndrome and stress cardiomyopathy added as possible adverse effects of duloxetine.
                        </div>
                    </div>
                    <div class="timeline-item">
                        <div class="timeline-date">January 2024</div>
                        <div class="timeline-content">
                            <strong>Minor Update:</strong> Information on licensed dose of desmopressin for women with troublesome nocturia and urgency incontinence added.
                        </div>
                    </div>
                    <div class="timeline-item">
                        <div class="timeline-date">September-October 2019</div>
                        <div class="timeline-content">
                            <strong>Review:</strong> Referral recommendations amended in line with 2015 NICE guideline Suspected cancer: recognition and referral.
                        </div>
                    </div>
                    <div class="timeline-item">
                        <div class="timeline-date">October-December 2014</div>
                        <div class="timeline-content">
                            <strong>Major Review:</strong> Choice of antimuscarinic drugs changed to align with NICE guidance. Mirabegron added as new drug option. New scenarios added for management of mixed UI, overflow incontinence, and urogenital fistula.
                        </div>
                    </div>
                </div>
            </section>
        </div>
    </main>

    <footer>
        <div class="container">
            <div class="copyright">© 2025 NICE Clinical Knowledge Summaries</div>
            <div class="disclaimer">The content on the NICE Clinical Knowledge Summaries site (CKS) is the copyright of Clarity Informatics Limited (trading as Agilio Software Primary Care).</div>
        </div>
    </footer>

    <script>
        // Navigation functionality
        document.addEventListener('DOMContentLoaded', function() {
            const navTabs = document.querySelectorAll('.nav-tab');
            const sections = document.querySelectorAll('.section');
            
            // Function to show section and update active tab
            function showSection(sectionId) {
                // Hide all sections
                sections.forEach(section => {
                    section.style.display = 'none';
                });
                
                // Show selected section
                const selectedSection = document.getElementById(sectionId);
                if (selectedSection) {
                    selectedSection.style.display = 'block';
                }
                
                // Update active tab
                navTabs.forEach(tab => {
                    tab.classList.remove('active');
                    if (tab.getAttribute('href') === `#${sectionId}`) {
                        tab.classList.add('active');
                    }
                });
            }
            
            // Add click event to nav tabs
            navTabs.forEach(tab => {
                tab.addEventListener('click', function(e) {
                    e.preventDefault();
                    const sectionId = this.getAttribute('href').substring(1);
                    showSection(sectionId);
                });
            });
            
            // Initially show only the overview section
            showSection('overview');
            
            // Smooth scroll for anchor links
            document.querySelectorAll('a[href^="#"]').forEach(anchor => {
                anchor.addEventListener('click', function (e) {
                    e.preventDefault();
                    const targetId = this.getAttribute('href').substring(1);
                    const targetElement = document.getElementById(targetId);
                    if (targetElement) {
                        window.scrollTo({
                            top: targetElement.offsetTop - 100,
                            behavior: 'smooth'
                        });
                    }
                });
            });
        });
    </script>
</body>
</html>